$184 Million is the total value of Kopp Family Office, LLC's 13 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 160.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Sell | NeoGenomics Inc. | $119,266,000 | -17.4% | 3,233,015 | -30.6% | 64.78% | -17.0% |
| HZNP | Buy | Horizon Therapeutics Public Limited Company | $33,205,000 | +88.9% | 427,465 | +35.1% | 18.04% | +89.9% |
| VCEL | Buy | Vericel Corporation | $21,323,000 | +42.6% | 1,150,735 | +6.3% | 11.58% | +43.3% |
| FIVN | Buy | Five9, Inc. | $8,627,000 | +21.8% | 66,525 | +4.0% | 4.69% | +22.5% |
| XENT | Intersect ENT Inc. | $1,266,000 | +20.5% | 77,630 | 0.0% | 0.69% | +21.1% | |
| ISTB | New | ISHARES TRcore 1 5 yr usd | $106,000 | – | 2,050 | +100.0% | 0.06% | – |
| IVV | New | ISHARES TRcore s&p500 etf | $98,000 | – | 292 | +100.0% | 0.05% | – |
| IEFA | New | ISHARES TRcore msci eafe | $71,000 | – | 1,178 | +100.0% | 0.04% | – |
| IAGG | New | ISHARES TRcore intl aggr | $44,000 | – | 783 | +100.0% | 0.02% | – |
| IMTB | New | ISHARES TRcr 5 10 yr etf | $40,000 | – | 764 | +100.0% | 0.02% | – |
| IJH | New | ISHARES TRcore s&p mcp etf | $27,000 | – | 147 | +100.0% | 0.02% | – |
| IEMG | New | ISHARES TRcore msci emkt | $17,000 | – | 316 | +100.0% | 0.01% | – |
| IJR | New | ISHARES TRcore s&p scp etf | $15,000 | – | 207 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.